Bacillus Calmette-Guerin, Mycobacterium bovis, as an Immunomodulator in Atopic Diseases

Immunology and Allergy Clinics of North America

Volumn 26, Issue 2, 2006, Pages 365-377

  Barlan, Isil ^a   Bahceciler, Nerin N ^a   Akdis, Mübeccel ^b   Akdis, Cezmi A ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BCG VACCINE; IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; LIVE VACCINE; OVALBUMIN; RECOMBINANT VACCINE; TOLL LIKE RECEPTOR;

ALLERGY; ATOPY; ATYPICAL MYCOBACTERIUM; BCG VACCINATION; CLINICAL TRIAL; ENVIRONMENTAL EXPOSURE; ETHNOLOGY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HOUSE DUST ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INNATE IMMUNITY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL; TUBERCULIN TEST; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ANIMALS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; HUMANS; IMMUNOLOGIC FACTORS; MICE; MYCOBACTERIUM BOVIS; TUBERCULIN;

EID: 33646411506     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2006.02.002     Document Type: Review

References (67)

1. Strachan D.P. Hay fever, hygiene, and household size. BMJ 299 (1989) 1259-1260
2. Rook G.A., and Hernandez-Pando R. Immunological and endocrinological characteristics of tuberculosis that provide opportunities for immunotherapeutic intervention. Novartis Found Symp 217 (1998) 73-87 [discussion: 87-98]
3. Shaheen S.O., Aaby P., Hall A.J., et al. Measles and atopy in Guinea-Bissau. Lancet 347 (1996) 1792-1796
4. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 (1996) 138-146
5. Taylor A., Verhagen J., Akdis C.A., et al. T regulatory cells in allergy and health: a question of allergen specificity and balance. Int Arch Allergy Immunol 135 (2004) 73-82
6. Akdis C.A., Blesken T., Akdis M., et al. Role of IL-10 in specific immunotherapy. J Clin Invest 102 (1998) 98-106
7. Akdis M., Verhagen J., Taylor A., et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199 (2004) 1567-1575
8. Jutel M., Akdis M., Budak F., et al. IL-10 and TGF-β cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33 (2003) 1205-1214
9. Brightbill H.D., Libraty D.H., Krutzik S.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
10. Shirakawa T., Enomoto T., Shimazu S., et al. The inverse association between tuberculin responses and atopic disorder. Science 275 (1997) 77-79
11. Gruber C., and Paul K.P. Tuberculin reactivity and allergy. Allergy 57 (2002) 277-280
12. Martinati L.C., and Boner A.L. The inverse relationship between tuberculin responses and atopic disorder. Allergy 52 (1997) 1036-1037
13. Sepulveda R.L., Heiba I.M., King A., et al. Evaluation of tuberculin reactivity in BCG-immunized siblings. Am J Respir Crit Care Med 149 (1994) 620-624
14. Aaby P., Shaheen S.O., Heyes C.B., et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 30 (2000) 644-650
15. Gruber C., Kulig M., Bergmann R., et al. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early bacille Calmette-Guerin-vaccinated and nonvaccinated children. Pediatrics 107 (2001) E36
16. Townley R.G., Barlan I.B., Patino C., et al. The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children. Ann Allergy Asthma Immunol 92 (2004) 350-355
17. Obihara C.C., Beyers N., Gie R.P., et al. Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in children. Allergy 60 9 (2005) 1121-1125
18. Alm J.S., Lilja G., Pershagen G., et al. BCG vaccination does not seem to prevent atopy in children with atopic heredity. Allergy 53 (1998) 537
19. von Mutius E., Pearce N., Beasley R., et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 55 (2000) 449-453
20. Shirtcliffe P., Weatherall M., and Beasley R. An inverse correlation between estimated tuberculosis notification rates and asthma symptoms. Respirology 7 (2002) 153-155
21. Von Hertzen L., Klaukka T., Mattila H., et al. Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions. J Allergy Clin Immunol 104 (1999) 1211-1214
22. Bibakis I., Zekveld C., Dimitroulis I., et al. Childhood atopy and allergic disease and skin test responses to environmental mycobacteria in rural Crete: a cross-sectional survey. Clin Exp Allergy 35 5 (2005) 624-629
23. Stenger S., and Modlin R.L. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol 14 4 (2002) 452-457
24. Heldwein K.A., and Fenton M.J. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 4 9 (2002) 937-944
25. Ria F., Penna G., and Adorini L. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells. Eur J Immunol 28 (1998) 2003-2016
26. Parronchi P., De Carli M., Manetti R., et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 149 (1992) 2977-2983
27. Randolph D.A., Carruthers C.J., Szabo S.J., et al. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 162 (1999) 2375-2383
28. Li X.M., Chopra R.K., Chou T.Y., et al. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol 157 (1996) 3216-3219
29. Gavett S.H., O'Hearn D.J., Li X., et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182 (1995) 1527-1536
30. Akdis C.A., Kussebi F., Pulendran B., et al. Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur J Immunol 33 (2003) 2717-2726
31. Bulut Y., Faure E., Thomas L., et al. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 167 2 (2001) 987-994
32. Hajjar A.M., O'Mahony D.S., Ozinsky A., et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166 1 (2001) 15-19
33. Means T.K., Wang S., Lien E., et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163 7 (1999) 3920-3927
34. Herz U., Gerhold K., Gruber C., et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 102 (1998) 867-874
35. Erb K.J., Holloway J.W., Sobeck A., et al. Infection of mice with Mycobacterium bovis-bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 187 (1998) 561-569
36. Wang C.C., and Rook G.A. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology 93 (1998) 307-313
37. Tukenmez F., Bahceciler N.N., Barlan I.B., et al. Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin-sensitized newborn mice. Pediatr Allergy Immunol 10 (1999) 107-111
38. Ozdemir C., Akkoc T., Bahceciler N.N., et al. Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma. Clin Exp Allergy 33 (2003) 266-270
39. Barlan I.B., Tukenmez F., Bahceciler N.N., et al. The impact of in vivo Calmette-Guerin bacillus administration on in vitro IgE secretion in atopic children. J Asthma 39 (2002) 239-246
40. Choi I.S., and Koh Y.I. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann Allergy Asthma Immunol 88 (2002) 584-591
41. Choi I.S., and Koh Y.I. Effects of BCG revaccination on asthma. Allergy 58 (2003) 1114-1116
42. Ozer A., Tukenmez F., Biricik A., et al. Effect of BCG vaccination on cytokine mRNA expression in atopic children with asthma. Immunol Lett 86 (2003) 29-35
43. Shirtcliffe P.M., Easthope S.E., Weatherall M., et al. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guerin in adult asthma. Clin Exp Allergy 34 (2004) 207-212
44. Husson R.N., James B.E., and Young R.A. Gene replacement and expression of foreign DNA in mycobacteria. J Bacteriol 172 2 (1990) 519-524
45. Aldovini A., and Young R.A. Development of a BCG recombinant vehicle for candidate AIDS vaccines. Int Rev Immunol 7 1 (1990) 79-83
46. Stover C.K., de la Cruz V.F., Fuerst T.R., et al. New use of BCG for recombinant vaccines. Nature 351 6326 (1991) 456-460
47. Aldovini A., and Young R.A. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351 6326 (1991) 479-482
48. Wang C.C., and Rook G.A. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology 93 3 (1998) 307-313
49. Arikan C., Bahceciler N.N., Deniz G., et al. Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 34 (2004) 398-405
50. Tsai J.J., Peng H.J., and Shen H.D. Therapeutic effect of bacillus Calmette-Guerin with allergen on human allergic asthmatic patients. J Microbiol Immunol Infect 35 (2002) 99-102
51. Kumar M., Behera A.K., Matsuse H., et al. A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice. Immunology 97 3 (1999) 515-521
52. Biet F., Duez C., Kremer L., et al. Recombinant Mycobacterium bovis BCG producing IL-18 reduces IL-5 production and bronchoalveolar eosinophilia induced by an allergic reaction. Allergy 60 8 (2005) 1065-1072
53. Wilczynski J.R. Th1/Th2 cytokines balance: yin and yang of reproductive immunology. Eur J Obstet Gynecol Reprod Biol 122 2 (2005) 136-143
54. Omenaas E., Jentoft H.F., Vollmer W.M., et al. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax 55 (2000) 454-458
55. Hopfenspirger M.T., and Agrawal D.K. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 168 (2002) 2516-2522
56. Alm J.S., Sanjeevi C.B., Miller E.N., et al. Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471. Genes Immun 3 (2002) 71-77
57. Karupiah G., Hunt N.H., King N.J., et al. NADPH oxidase, Nramp1 and nitric oxide synthase 2 in the host antimicrobial response. Rev Immunogenet 2 (2000) 387-415
58. Smit J.J., Van Loveren H., Hoekstra M.O., et al. The Slc11a1 (Nramp1) gene controls efficacy of mycobacterial treatment of allergic asthma. J Immunol 171 (2003) 754-760
59. Smit J.J., Folkerts G., and Nijkamp F.P. Mycobacteria, genes and the 'hygiene hypothesis'. Curr Opin Allergy Clin Immunol 4 (2004) 57-62
60. Poon A.H., Laprise C., Lemire M., et al. NRAMP1 is not associated with asthma, atopy, and serum immunoglobulin E levels in the French Canadian population. Genes Immun 6 6 (2005) 519-527
61. Brandt L., Feino Cunha J., Weinreich Olsen A., et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70 (2002) 672-678
62. Colditz G.A., Brewer T.F., Berkey C.S., et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271 (1994) 698-702
63. Demangel C., Garnier T., Rosenkrands I., et al. Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect Immun 73 (2005) 2190-2196
64. Zuany-Amorim C., Sawicka E., Manlius C., et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 8 (2002) 625-629
65. Zuany-Amorim C., Manlius C., Trifilieff A., et al. Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J Immunol 169 (2002) 1492-1499
66. Walker C., Sawicka E., and Rook G.A. Immunotherapy with mycobacteria. Curr Opin Allergy Clin Immunol 3 (2003) 481-486
67. Adams V.C., Hunt J.R., Martinelli R., et al. Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice. Eur J Immunol 34 (2004) 631-638